发明名称 PHARMACEUTICAL COMPOSITIONS COMPRISING CLAVULANIC ACID OR DERIVATIVE THEREOF FOR THE TREATMENT OF BEHAVIORAL DISEASES
摘要 Administration of certain beta -lactam compounds, has been found to provide significant neurotropic effects in warm-blooded vertebrates evidenced <i>inter alia</i> by anxiolytic and anti-aggressive behavior and enhanced cognition believed to be mediated by inhibition of neurogenic NAALADase and related neurogenic enzyme activity. The beta -lactamase inhibitor, clavulanic acid exhibits potent NAALADase inhibition, and it exhibits good blood brain barrier transport to provide effective inhibition of neurogenic NAALADase with significant neuro-therapeutic effects. Clavulanate acid and related compounds are useful, for example, for treatment of anxiety, anti-aggressive disorders, memory impairment, and disease states characterized by glutamate abnormalities. Therapeutic methods for using such compounds and their pharmaceutical formulations are described.
申请公布号 WO0112171(A3) 申请公布日期 2002.01.17
申请号 WO2000US22434 申请日期 2000.08.16
申请人 REVAAX PHARMACEUTICALS, LLC 发明人 KOPPEL, GARY, A.
分类号 A61K45/00;A61K31/00;A61K31/197;A61K31/198;A61K31/395;A61K31/424;A61K31/43;A61K31/431;A61K31/4353;A61K31/4365;A61K31/437;A61K31/5365;A61K31/5383;A61K31/545;A61K31/546;A61K31/553;A61K38/08;A61K45/06;A61P3/06;A61P25/00;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P43/00;(IPC1-7):A61K31/423 主分类号 A61K45/00
代理机构 代理人
主权项
地址